Triple-negative breast cancer (TNBC) is a breast cancer subtype that is immunohistochemically negative for the estrogen receptor (ER) and for the progesterone receptor (PR), and is also associated with the absence of HER2 protein overexpression and/or HER2 gene amplification [23]. The gene discussed is ESR1; the disease is breast carcinoma.